Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: Implications for pathogenesis

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 5, 1997, Pages 347-358

  Bakowski, Marie T ^a   Prescott, Philip ^b  

^a Solvay Healthcare Ltd   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cystic fibrosis; Enteric coating; Fibrosing colonopathy; Pancreatic enzyme supplements

Indexed keywords

KREON; NUTRIZYME; PANCREAS ENZYME; PANCREATIN; PANCRELIPASE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COLON DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG FORMULATION; DRUG INDUCED DISEASE; ENTERIC COATED TABLET; FIBROSIS; HUMAN; PANCREAS DISEASE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL;

EID: 0030782086     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199709/10)6:5<347::AID-PDS305>3.0.CO;2-2     Document Type: Article

References (17)

1. Dimagno, E. P., Malagelada, J. R., Go, V. L. W. and Moertel, C. G. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. New England Journal of Medicine 1977; 296: 1318-1322.
2. Meyer, J. H., Elashoff, J., Porter-Fink, V., Dressman, J. and Amidon, G. L. Human postprandial gastric emptying of 1-3 millimeter spheres. Gastroenterology 1988; 94: 1315-1325.
3. Rheinstein, P. H. Regulatory status of pancreatic enzyme preparations. Journal of the American Medical Association 1990, 263: 2491-2492.
4. Smyth, R. L., van Velzen, D., Smyth, A. R., Lloyd, D. A. and Heaf, D. P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 85-86.
5. Smyth, R. L., Ashby, D., O'Hea, U. et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247-1251.
6. Freiman, J. P. FDA report on the survey for strictures in the Cystic Fibrosis Foundation database. March 1994.
7. Freiman, J. P. and FitzSimmons, S. C. Colonic strictures in patients with cystic fibrosis: Results of a survey of 114 cystic fibrosis care centers in the United States. Journal of Pediatric Gastroenterology and Nutrition 1996; 22: 153-156.
8. Jones, R., Franklin, K., Spicer, R. and Berry, J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346: 499.
9. O'Keefe, P. Case report. Postgraduate Medical Journal 1996; 72(2): S23-S25.
10. Dodge, J. A. Fibrosing colonopathy: recent advances. Journal of the Royal Society of Medicine 1996; 89 (Suppl. 27): 19-23.
11. Lloyd-Still, J. D. Editorial: Cystic Fibrosis and Colonic Strictures. A new 'tatrogenic' disease. Journal of Clinical Gastroenterology 1995; 21(1): 2-5.
12. Van Velzen, D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346: 499-500.
13. World Health Organisation. Pancreatic enzyme supplements and fibrosing colonopathy. WHO Drug Information 1996; 10: 43-44.
14. European Centre for Ecotoxicology and Toxicology of Chemicals. Joint assessment of commodity chemicals No. 28: ethyl acrylate, CAS No. 140-88-5, Brussels, September 1994.
15. European Centre for Ecotoxicology and Toxicology of Chemicals. Joint assessment of commodity chemicals No. 35: methacrylic acid, CAS No. 79-41-4, Brussels, April 1996.
16. Ghanayem, B. I., Maronpot, R. R. and Matthews, H. B. Ethyl acrylate-induced gastric toxicity. III. Development and recovery of lesions. Toxicology and Applied Pharmacology 1986; 83: 576-583.
17. Medicines Control Agency/Committee on Safety of Medicines. Fibrosing colonopathy associated with pancreatic enzymes. Current Problems in Pharmacovigilance 1995; 21: 11.